Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Hepatobiliary Diseases Topic Center

Featured Article

Agopian
Conference Coverage
Integrating Surgical and Systemic Approaches to HCC
01/10/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Dr Vatche G. Agopian provided an overview of how surgery and systemic therapy can be combined to improve outcomes for patients with hepatocellular carcinoma at the International Society of Gastrointestinal Cancer meeting on October 13.
Dr Vatche G. Agopian provided an overview of how surgery and systemic therapy can be combined to improve outcomes for patients with hepatocellular carcinoma at the International Society of Gastrointestinal Cancer meeting on October 13.
Dr Vatche G. Agopian provided an...
01/10/2024
Gastroenterology
liver
Conference Coverage
Mixed CCA/HCC Tumors: A Real Thing
10/17/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Rare and often refractory, mixed cholangiocarcinoma-hepatocellular tumors present diagnostic and treatment challenges that may require a variety of agents in combination, according to Binbin Zheng-Lin, MD.
Rare and often refractory, mixed cholangiocarcinoma-hepatocellular tumors present diagnostic and treatment challenges that may require a variety of agents in combination, according to Binbin Zheng-Lin, MD.
Rare and often refractory, mixed...
10/17/2023
Gastroenterology
Nilofer Azad
Conference Coverage
Biliary Tract Cancer: Where Are We Headed?
10/14/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Dr Nilofer Azad of Johns Hopkins University reviewed the progress and unmet needs for treatment of biliary tract cancer at the International Society of Gastrointestinal Oncology conference in Tempe, Arizona.
Dr Nilofer Azad of Johns Hopkins University reviewed the progress and unmet needs for treatment of biliary tract cancer at the International Society of Gastrointestinal Oncology conference in Tempe, Arizona.
Dr Nilofer Azad of Johns Hopkins...
10/14/2023
Gastroenterology
Quiz
Combo Therapy for uHCC
08/16/2023
Researchers have found a combination of two agents to demonstrate superior efficacy and a favorable benefit-risk profile among patients with unresectable hepatocellular carcinoma. Take our quiz to find out which combo could improve overall...
Researchers have found a combination of two agents to demonstrate superior efficacy and a favorable benefit-risk profile among patients with unresectable hepatocellular carcinoma. Take our quiz to find out which combo could improve overall...
Researchers have found a...
08/16/2023
Gastroenterology
News
Imaging, Biomarkers May Improve Hepatocellular Carcinoma Surveillance
03/30/2023
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and...
03/30/2023
Gastroenterology
Infusion
News
ICIs Analyzed as First-Line Therapies for HCC
03/22/2023
Investigators conducted a systematic review and network meta-analysis to determine whether immune checkpoint inhibitors evidenced efficacy and safety as first-line agents for the treatment for unresectable hepatocellular carcinoma.
Investigators conducted a systematic review and network meta-analysis to determine whether immune checkpoint inhibitors evidenced efficacy and safety as first-line agents for the treatment for unresectable hepatocellular carcinoma.
Investigators conducted a...
03/22/2023
Gastroenterology
Liver drawing
News
Predictors of Immunotherapy Response in Hepatobiliary Malignancies Remain Elusive
03/16/2023
The search continues for biomarkers that will help identify patients likely to respond to immunotherapy for hepatobiliary cancer.
The search continues for biomarkers that will help identify patients likely to respond to immunotherapy for hepatobiliary cancer.
The search continues for...
03/16/2023
Gastroenterology
Coffee
Quiz
Quiz: Screening for HCC
03/14/2023
What did the findings of a recent study show regarding the screening of patients with nonalcoholic fatty liver disease-related cirrhosis for hepatocellular carcinoma?
What did the findings of a recent study show regarding the screening of patients with nonalcoholic fatty liver disease-related cirrhosis for hepatocellular carcinoma?
What did the findings of a...
03/14/2023
Gastroenterology
News
Gastrointestinal, Hepatic Manifestations Affect Many with COVID-19
03/02/2023
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause...
03/02/2023
Gastroenterology
News
HIMALAYA Trial Examines Treatment-Emergent ADAs for Durvalumab in HCC Regimens
02/24/2023
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may...
02/24/2023
Gastroenterology
News
Biomarkers To Predict ICI Response in Hepatobiliary Cancers “Urgently” Needed
02/08/2023
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates...
02/08/2023
Gastroenterology

News

News
Imaging, Biomarkers May Improve Hepatocellular Carcinoma Surveillance
03/30/2023
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and...
03/30/2023
Gastroenterology
News
Gastrointestinal, Hepatic Manifestations Affect Many with COVID-19
03/02/2023
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause...
03/02/2023
Gastroenterology
News
HIMALAYA Trial Examines Treatment-Emergent ADAs for Durvalumab in HCC Regimens
02/24/2023
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may...
02/24/2023
Gastroenterology
News
Biomarkers To Predict ICI Response in Hepatobiliary Cancers “Urgently” Needed
02/08/2023
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates...
02/08/2023
Gastroenterology
News
Durvalumab Plus Tremelimumab Improves Survival in Unresectable HCC
01/17/2023
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab...
01/17/2023
Gastroenterology
News
Disparities in Access to Immunotherapy for HCC
01/13/2023
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are...
01/13/2023
Gastroenterology
News
Patient-Reported Barriers to HCC Surveillance
01/04/2023
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in...
01/04/2023
Gastroenterology
News
Robotic Liver Resection for Hepatocellular Carcinoma Offers Oncologic Efficacy, Safety
12/28/2022
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers...
12/28/2022
Gastroenterology
News
CCA Diagnostic Tools Reviewed for Comparative Sensitivity
12/19/2022
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of...
12/19/2022
Gastroenterology
News
Did the Pandemic Affect HCC Surveillance?
11/29/2022
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find...
11/29/2022
Gastroenterology
News
Multivariable Model Outperforms Guideline-Based Model for Predicting CRC
05/14/2024

Jolynn Tumolo

Jolynn Tumolo
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model...
05/14/2024
Gastroenterology
News
CRC Rate Rising Among Younger Americans
05/14/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate...
05/14/2024
Gastroenterology
News
MASLD Identified as Osteoarthritis Risk Marker in US Adults
05/03/2024

Jolynn Tumolo

Jolynn Tumolo
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated...
05/03/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
04/08/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
04/08/2024
Advances in Inflammatory Bowel Disease Network
News
IBS Prevalence Slightly Above 6% in Pandemic-Era US Survey
03/28/2024

Jolynn Tumolo

Jolynn Tumolo
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed...
03/28/2024
Gastroenterology
News
H. Pylori Infection Studied for Association With Colorectal Cancer
03/12/2024

Jolynn Tumolo

Jolynn Tumolo
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter...
03/12/2024
Gastroenterology
News
Metabolic Health Does Not Protect Against Erosive Esophagitis in Adults With Obesity
03/08/2024

Jolynn Tumolo

Jolynn Tumolo
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body...
03/08/2024
Gastroenterology
News
Intrarectal Injections of BoNTA for Fecal Incontinence?
03/04/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate...
03/04/2024
Gastroenterology
News
GLP-1 Treatment Associated With Lower CRC Risk
02/27/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2...
02/27/2024
Gastroenterology
News
1 in 5 Patients with Erosive Esophagitis Cycles Through PPIs
02/23/2024

Jolynn Tumolo

Jolynn Tumolo
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump...
02/23/2024
Gastroenterology

Videos

Alan Bonder
Conference Coverage
Alan Bonder, MD, on Primary Biliary Cholangitis
01/05/2022
Alan Bonder, MD, medical director of liver transplantation at Beth Israel Deaconess Medical Center in Boston, discusses key presentations of research on primary biliary cholangitis presented at the 2021 meeting of the American Association for...
Alan Bonder, MD, medical director of liver transplantation at Beth Israel Deaconess Medical Center in Boston, discusses key presentations of research on primary biliary cholangitis presented at the 2021 meeting of the American Association for...
Alan Bonder, MD, medical...
01/05/2022
Gastroenterology
Brian Lacy
Conference Coverage
Brian Lacy, MD, on Food Allergies and Sensitivities
11/22/2023
Dr Brian Lacy of Mayo Clinic-Florida dispels some myths and clarifies the issues surrounding food allergies and food sensitivities and provides guidance in how to treat both conditions.
Dr Brian Lacy of Mayo Clinic-Florida dispels some myths and clarifies the issues surrounding food allergies and food sensitivities and provides guidance in how to treat both conditions.
Dr Brian Lacy of Mayo...
11/22/2023
Gastroenterology
Conference Coverage
Paul Kwo, MD, on the Changing Face of Liver Disease
10/23/2023
Dr Kwo focused his David Sun Lecture at the ACG Postgraduate Course on the increasing burden of metabolic-associated fatty liver disease and the need to step up efforts to increase access to effective treatments now available for patients...
Dr Kwo focused his David Sun Lecture at the ACG Postgraduate Course on the increasing burden of metabolic-associated fatty liver disease and the need to step up efforts to increase access to effective treatments now available for patients...
Dr Kwo focused his David Sun...
10/23/2023
Gastroenterology
Rena Yadlapati
Conference Coverage
Rena Yadlapati, MD, on the Difficult-to-Treat Patient With GERD
10/23/2023
Dr Yadlapati provides guidance in the options for caring for patients who present with GERD that does not respond adequately to treatment.
Dr Yadlapati provides guidance in the options for caring for patients who present with GERD that does not respond adequately to treatment.
Dr Yadlapati provides guidance...
10/23/2023
Gastroenterology
Brian Lacy
Conference Coverage
Brian Lacy, MD, on Tenapanor for IBS-C
10/23/2023
Dr Lacy recaps the key points of his presentation on the use of tenapanor for the treatment of irritable bowel syndrome with constipation, which received the Outstanding Research Award in the Colon Category and was noted as a Newsworthy...
Dr Lacy recaps the key points of his presentation on the use of tenapanor for the treatment of irritable bowel syndrome with constipation, which received the Outstanding Research Award in the Colon Category and was noted as a Newsworthy...
Dr Lacy recaps the key points of...
10/23/2023
Gastroenterology
Aasma Shaukat
Conference Coverage
45 is the New 50: Aasma Shaukat, MD, on Meeting Demands for CRC Screening
10/22/2023
Dr Shaukat recaps her presentation on the increasing numbers of patients who will need screening colonoscopy now that the beginning age for colorectal screening has been lowered to 45 from 50, and methods that gastroenterology can take as a...
Dr Shaukat recaps her presentation on the increasing numbers of patients who will need screening colonoscopy now that the beginning age for colorectal screening has been lowered to 45 from 50, and methods that gastroenterology can take as a...
Dr Shaukat recaps her...
10/22/2023
Gastroenterology
Blanca Lizaolo-Mayo
Video
Blanca Lizaola-Mayo, MD, on Changes in Nomenclature for Liver Diseases
09/20/2023
Dr Lizaolo-Mayo explains the recent changes in nomenclature from nonalcoholic fatty liver disease and why these changes were implemented.
Dr Lizaolo-Mayo explains the recent changes in nomenclature from nonalcoholic fatty liver disease and why these changes were implemented.
Dr Lizaolo-Mayo explains the...
09/20/2023
Gastroenterology
Sarah Khan
Video
Sarah Khan, MD, on Outcomes in Liver Patients With Fungal and Bacterial Infection
05/15/2023
Dr Khan recaps the results of research at Cleveland Clinic on how patients with acute-on-chronic liver failure with bacterial infections vs fungal infections fared in terms of mortality and other metrics.
Dr Khan recaps the results of research at Cleveland Clinic on how patients with acute-on-chronic liver failure with bacterial infections vs fungal infections fared in terms of mortality and other metrics.
Dr Khan recaps the results of...
05/15/2023
Gastroenterology
Fola May
Conference Coverage
Folasade May, MD, on Strategies to Maximize Colorectal Cancer Screening
05/09/2023
Dr May recaps a late-breaking abstract from Digestive Disease Week 2023 reporting results from a randomized trial her team conducted to determine the best strategies for increasing rates of screening for colorectal cancer among unscreened...
Dr May recaps a late-breaking abstract from Digestive Disease Week 2023 reporting results from a randomized trial her team conducted to determine the best strategies for increasing rates of screening for colorectal cancer among unscreened...
Dr May recaps a late-breaking...
05/09/2023
Gastroenterology
Astrid Ruiz Margain
Video
Astrid Ruiz Margain, PhD, on Nutrition and Liver Disease
02/01/2023
Dr Ruiz reviews key presentations on nutrition in liver disease from the AASLD meeting, with emphasis on outcomes in cirrhosis related to sarcopenia, liver transplant, hepatocellular carcinoma, and nutritional therapy.
Dr Ruiz reviews key presentations on nutrition in liver disease from the AASLD meeting, with emphasis on outcomes in cirrhosis related to sarcopenia, liver transplant, hepatocellular carcinoma, and nutritional therapy.
Dr Ruiz reviews key...
02/01/2023
Gastroenterology
Lim
Video
Nicholas Lim, MD, on Updates in Liver Transplantation
01/31/2023
Dr Lim reviews key findings from abstracts at The Liver Meeting 2022 pertaining to liver transplantation.
Dr Lim reviews key findings from abstracts at The Liver Meeting 2022 pertaining to liver transplantation.
Dr Lim reviews key findings from...
01/31/2023
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Imaging, Biomarkers May Improve Hepatocellular Carcinoma Surveillance
03/30/2023
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and...
03/30/2023
Gastroenterology
News
Gastrointestinal, Hepatic Manifestations Affect Many with COVID-19
03/02/2023
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause...
03/02/2023
Gastroenterology
News
HIMALAYA Trial Examines Treatment-Emergent ADAs for Durvalumab in HCC Regimens
02/24/2023
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may...
02/24/2023
Gastroenterology
News
Biomarkers To Predict ICI Response in Hepatobiliary Cancers “Urgently” Needed
02/08/2023
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates...
02/08/2023
Gastroenterology
News
Durvalumab Plus Tremelimumab Improves Survival in Unresectable HCC
01/17/2023
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab...
01/17/2023
Gastroenterology
News
Disparities in Access to Immunotherapy for HCC
01/13/2023
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are...
01/13/2023
Gastroenterology
News
Patient-Reported Barriers to HCC Surveillance
01/04/2023
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in...
01/04/2023
Gastroenterology
News
Robotic Liver Resection for Hepatocellular Carcinoma Offers Oncologic Efficacy, Safety
12/28/2022
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers...
12/28/2022
Gastroenterology
News
CCA Diagnostic Tools Reviewed for Comparative Sensitivity
12/19/2022
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of...
12/19/2022
Gastroenterology
News
Did the Pandemic Affect HCC Surveillance?
11/29/2022
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find...
11/29/2022
Gastroenterology
News
Multivariable Model Outperforms Guideline-Based Model for Predicting CRC
05/14/2024

Jolynn Tumolo

Jolynn Tumolo
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model...
05/14/2024
Gastroenterology
News
CRC Rate Rising Among Younger Americans
05/14/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate...
05/14/2024
Gastroenterology
News
MASLD Identified as Osteoarthritis Risk Marker in US Adults
05/03/2024

Jolynn Tumolo

Jolynn Tumolo
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated...
05/03/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
04/08/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
04/08/2024
Advances in Inflammatory Bowel Disease Network
News
IBS Prevalence Slightly Above 6% in Pandemic-Era US Survey
03/28/2024

Jolynn Tumolo

Jolynn Tumolo
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed...
03/28/2024
Gastroenterology
News
H. Pylori Infection Studied for Association With Colorectal Cancer
03/12/2024

Jolynn Tumolo

Jolynn Tumolo
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter...
03/12/2024
Gastroenterology
News
Metabolic Health Does Not Protect Against Erosive Esophagitis in Adults With Obesity
03/08/2024

Jolynn Tumolo

Jolynn Tumolo
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body...
03/08/2024
Gastroenterology
News
Intrarectal Injections of BoNTA for Fecal Incontinence?
03/04/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate...
03/04/2024
Gastroenterology
News
GLP-1 Treatment Associated With Lower CRC Risk
02/27/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2...
02/27/2024
Gastroenterology
News
1 in 5 Patients with Erosive Esophagitis Cycles Through PPIs
02/23/2024

Jolynn Tumolo

Jolynn Tumolo
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump...
02/23/2024
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement